Analytical Data
-
Gene name
GNg2
- Application
-
Alternative Names
Guanine Nucleotide Binding Protein Gamma 2; Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P59768
-
Expression Region
Ala2~Leu71
-
Molecular Weight
12kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GNg2 recombinant protein has garnered increasing attention in recent years due to its pivotal role in various cellular processes, particularly in the regulation of G protein-coupled receptors (GPCRs) and downstream signaling pathways. GPCRs are fundamental in mediating numerous physiological functions and represent significant targets for therapeutic interventions. GNg2, as a subunit of the heterotrimeric G protein complex, is implicated in a myriad of cellular responses, including those associated with growth, hormone signaling, and sensory perception. Research into GNg2 recombinant protein aims to elucidate its structure-function relationships and explore its regulatory mechanisms within the context of GPCR signaling. Advances in recombinant DNA technology have facilitated the production of GNg2 in heterologous systems, allowing for detailed biochemical and biophysical characterization. Furthermore, studies investigating GNg2 interactions with specific GPCRs have the potential to unveil novel pharmacological targets and contribute to the development of innovative therapeutic strategies for various diseases, including cancer, cardiovascular disorders, and neurological conditions. As this field of study continues to evolve, the intricate functionalities of GNg2 protein in health and disease will likely provide crucial insights into cellular communication and therapeutic advancements.
